Skincare App & Scanner Comparison

The most legitimately useful tool here — precisely because it is real medical care, not an algorithm grading a selfie. For mild-to-moderate acne, custom prescription topicals chosen by a licensed provider genuinely work, and the ingredients are well-evidenced. Just know it is a subscription, asynchronous review has limits, and anything severe or atypical still needs an in-person dermatologist.

INCI Beauty is a French app that decodes ingredient lists using the EU CosIng database and published toxicological references. Unlike Think Dirty or EWG, it focuses on what an ingredient is rather than assigning it an arbitrary "danger" score. It shows EU regulatory status, common function categories, and known sensitisation potential — with appropriate context. The most honest and scientifically grounded ingredient scanner currently available for iOS and Android. Most useful for understanding unfamiliar INCI names; not a substitute for dermatological assessment of whether a product suits your specific skin.

Miiskin is not a diagnostic tool — it is a documentation tool, and that restraint is its strength. It helps users photograph, label, and track moles and skin lesions over time so that changes are objectively visible across months. The AAD recommends monthly self-skin exams, and consistent photo documentation is a rational complement to that practice. If you bring a structured, dated photo history to a dermatologist appointment, it may meaningfully improve the clinical encounter. Miiskin does not attempt to diagnose, which means it does not mislead. Verdict: worth it as a documentation discipline, within clearly stated limits.

One of the more grounded brand tools, because acne grading is a real clinical task and it was trained on dermatologist-graded images. Genuinely handy for tracking breakout severity over time for free — just remember it grades rather than diagnoses, and every recommendation is a La Roche-Posay product.

A questionnaire-based product-matching service dressed in "AI" and "skin genome" language. The actives can be perfectly fine, but there is no independent evidence the custom blends beat a sensible off-the-shelf routine. Worth it only if you value the convenience of personalization — not because the "AI" is doing anything clinically proven.

A genuine medical-risk tool, not a cosmetic gimmick — but treat it strictly as a prompt to see a doctor, never a substitute for one. It is CE-marked in Europe and NOT FDA-cleared in the US, and independent research says it both misses some cancers and over-flags benign spots. Useful as an extra nudge to get a worrying mole examined; dangerous if a "low risk" result falsely reassures you.

The skin "analysis" is essentially a moisture sensor plus a made-up "skin age", bundled to justify a cleansing gadget. The cleansing brush itself may be pleasant to use, but do not buy it for the analytics — there is no independent evidence the readings mean much.

Treat the whole genre as entertainment with a sales funnel attached. A selfie "skin score" is not a standardised or independently validated metric, it shifts with your lighting, and the recommendations usually exist to sell you something. Useful as a mirror that points you toward topics to read up on here — not as measurement or diagnosis.

A polished selfie-to-"skin age" marketing tool from a single brand. The skin-age number is a proprietary construct, not a clinical measure, and every recommendation routes to Olay. Harmless fun; not a neutral or medical assessment.

Fun and slick, but be clear about what it is: a beauty-retail conversion tool, not a clinical assessment. The "skin score" is not a standardised medical metric, the accuracy is not independently validated, and the recommendations exist to sell product. Fine as a mirror with opinions; do not make health decisions on it.

Think Dirty assigns every ingredient a "dirty" score from 0–10 based on hazard classification data. The methodology conflates hazard with risk: an ingredient flagged as harmful at high doses in an animal study receives a high dirty score regardless of the trace concentration it appears in at in a face cream. This is the same logical error as rating water dangerous because humans can drown in it. The scores are not peer-reviewed, and the app operates a product marketplace that benefits commercially from high dirty scores on competitor ingredients. An ingredient lookup tool; not an accurate safety-assessment tool.

The Environmental Working Group's Skin Deep database rates over 70,000 cosmetic products on a 1–10 hazard scale. Like Think Dirty, it uses hazard-based rather than risk-based assessment, without accounting for concentration or exposure context. The EWG is an advocacy organisation, not a scientific body, and its ratings are systematically more conservative than regulatory consensus — they frequently contradict positions held by the FDA, EU Scientific Committee on Consumer Safety (SCCS), and AAD. Useful as a large ingredient lookup; not reliable as a safety authority. The scoring methodology has been publicly criticised by toxicologists and dermatologists for creating unwarranted concern.

CosDNA is widely used to check whether ingredients might be comedogenic (pore-clogging). The problem is its comedogenicity data source: rabbit ear assays conducted in the 1970s and 1980s that have been repeatedly criticised by dermatologists as poorly predictive of human acne. Multiple ingredients routinely flagged by CosDNA as high-comedogenicity are used safely by acne-prone individuals. The correlation between rabbit ear assay results and human comedogenicity is weak. Useful as an ingredient lookup tool; treat the comedogenicity scores — specifically the numerical ratings — with significant scepticism.

Included as a cautionary case study, not a recommendation. These melanoma-risk apps were sanctioned by the U.S. FTC in 2015 for deceptive claims they could not back up. They are the clearest example of why "AI can detect your skin cancer" marketing deserves deep skepticism — a falsely reassuring result can be dangerous.

Neutrogena launched the Skin360 face scanner in 2018 — a 30× magnifying iPhone attachment using fluorescent light and AI analysis to assess pores, dark spots, and fine lines. It was quietly discontinued within two years. The hardware is no longer available or supported. Included here as an important case study: a major consumer brand launched a premium "science-backed" skin scanner, positioned it as clinical-grade technology, and withdrew it without ever publishing peer-reviewed accuracy data or obtaining FDA clearance as a medical device. The pattern — consumer hardware scanner with clinical-sounding language, no independent validation, discontinued — is worth knowing because similar products continue to launch under different brand names.